Product Images Methscopolamine Bromide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Methscopolamine Bromide NDC 81005-127 by Aarkish Pharmaceuticals Nj Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

methscopolamine-aarkish-carton1 - methscopolamine aarkish carton1

methscopolamine-aarkish-carton1 - methscopolamine aarkish carton1

This text provides information about Methscopolamine Bromide tablets containing 2.5 mg of the active ingredient. It includes details on the usual adult dosage, inactive ingredients, storage instructions, and manufacturer details. The tablets are prescribed for oral administration and come in a pack containing 100 tablets. The product should be stored in a light-resistant container at a controlled room temperature.*

methscopolamine-aarkish-carton2 - methscopolamine aarkish carton2

methscopolamine-aarkish-carton2 - methscopolamine aarkish carton2

Each tablet for oral administration contains 2.5 mg of Methscopolamine Bromide, USP. The usual adult dosage is provided in the package insert. The product information includes approved impurity specifications from the USP. The tablets are made with ingredients like microcrystalline cellulose, croscarmellose sodium, colloidal silicon dioxide, and magnesium stearate. Dispense in a tight, light-resistant container and store at 20° to 25°C (68° to 77°F). Distributed by Rarkish Pharmaceuticals Inc. in New Jersey. Made in the USA.*

methscopolamine-aarkish-carton3 - methscopolamine aarkish carton3

methscopolamine-aarkish-carton3 - methscopolamine aarkish carton3

Each tablet contains 5 mg of Methscopolamine Bromide, USP for oral administration. The usual adult dosage should be referred to the package insert or complete product information. The FDA approved impurity specifications may differ from the USP. The tablets contain inactive ingredients such as microcrystalline cellulose, pregelatinized starch, colloidal silicon dioxide, and magnesium stearate. They do not contain lactose. The tablets need to be dispensed in a tight, light-resistant container and stored at a temperature between 20°C to 25°C (68°F to 77°F). Distributed by Aarkish Pharmaceuticals Inc. This product is a prescription-only item and each package contains 60 tablets.*

methscopolamine-aarkish-carton4 - methscopolamine aarkish carton4

methscopolamine-aarkish-carton4 - methscopolamine aarkish carton4

This is a medication information for a Methscopolamine Bromide tablet containing 5 mg of the active ingredient. It is intended for oral administration in adults and is available in a package of 1000 tablets. The medication should be stored in a light-resistant container at a temperature of 20 to 25°C (68° to 77°F). Please refer to the package insert for detailed dosage instructions and product information.*

methscopolamine-aarkish-structure - methscopolamine aarkish structure

methscopolamine-aarkish-structure - methscopolamine aarkish structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.